PedAM
Pediatric Disease Annotations & Medicines
| Disease | leukemia |
| Phenotype | C0023473|chronic myelogenous leukemia |
| Sentences | 3 |
| PubMedID- 21302443 | Objective: to study the proliferative inhibition effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with ph(+), chronic myelogenous leukemia cell line k562 expressing p210 protein and acute lymphoblastic leukemia cell line sup-b15 expressing p190 protein. |
| PubMedID- 23738923 | Objective: molecular monitoring using quantitative polymerase chain reaction (qpcr) of bcr-abl mrna transcripts using the international scale (is) is recommended by the national comprehensive cancer network and the european leukemianet for patients with chronic myelogenous leukemia in chronic phase (cml-cp). |
| PubMedID- 24152491 | Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia. |
Page: 1